Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474317 · ClinicalTrials.gov registry record · NA
Study of an Investigational Glucose Meter System
A NA study, sponsored by Ascensia Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
NCT01474317 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 226 participants.
The verdict
NCT01474317, a NA study, has completed, sponsored by Ascensia Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that untrained subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.
Interventions
- DEVICE G3 Investigational Blood Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2011-11 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01474317
The ClinicalTrials.gov registry entry for NCT01474317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which G3 Investigational Blood Glucose Monitoring System is the first listed.
NCT01474317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01474317 about?
NCT01474317 is a clinical study titled "Study of an Investigational Glucose Meter System". The purpose of this study is to demonstrate that untrained subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.
What is the current status of trial NCT01474317?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2011-11. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01474317?
The interventions under investigation include: G3 Investigational Blood Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT01474317?
This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.